Dr Lal Pathlabs Ltd
₹1635.80
as on
Dr Lal Pathlabs Stock Performance
as on June 19, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,622.40₹1,677.00
0.82%
Downside
2.52%
Upside
52 Week's Low
52 Week's High
₹1,272.60₹1,803.0022.20%
Downside
10.22%
Upside
Dr Lal Pathlabs share price movements today
- Previous Close
- ₹1,662.90
- Open
- ₹1,660.20
- Volume
- 2.27L
- Upper Circuit
- ₹1,995.40
- Lower Circuit
- ₹1,330.40
- Day's Low - High
- ₹1,622.40 - ₹1,677.00
- 52 Week Low - High
- ₹1,272.60 - ₹1,803.00
Dr Lal Pathlabs Historical Returns
- 1 Month Return
- -2.39 %
- 3 Month Return
- + 25.46 %
- 1 Year Return
- + 15.49 %
- 3 Year Return
- + 56.79 %
- 5 Year Return
- + 5.52 %
Dr Lal Pathlabs Fundamentals
as on June 19, 2026 at 4:01 pm IST
Market Cap
₹27,876.48 Cr
Return on Equity (ROE)
25.27
PE Ratio (TTM)
54.98
Return on capital employed (ROCE)
29.72
Industry PE ratio
52.35
Beta (LTM)
0P/B Ratio
9.71
Dividend Yield
0.97
PEG Ratio
54.71
Quarterly Earnings Growth YOY
-14.98
EPS (TTM)
29.445
Book Value
129.96
Dr Lal Pathlabs Stock Valuation
as on June 19, 2026 at 4:01 pm IST
Dr Lal Pathlabs in the last 5 years
Lowest (37.51x)
November 16, 2018
Industry (52.35x)
June 18, 2026
Today (54.98x)
June 18, 2026
Highest (95.62x)
November 5, 2020
Today’s Price to Earnings Ratio: 54.98x
Dr Lal Pathlabs Technical Analysis
Track how Dr Lal Pathlabs technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 1.05 | |
CCI (20) | 259.47 | |
RSI (14) | 56.52 | Neutral |
Momentum (10) | -1.9 | Bullish |
ADI (14) | 33.99 | |
Ultimate Oscillator (7,14,28) | 36.52 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1638.52 | |
EMA (20) | 1636.47 | Bullish |
VWMA (20) | 1637.7 | Bullish |
SMA (50) | 1631.47 | Bullish |
EMA (50) | 1633.53 | Bullish |
SMA (200) | 1632.21 | Bullish |
EMA (200) | 1633.96 | Bullish |
KAMA (200) | 1633.57 | Bullish |
DEMA (200) | 1628.32 | Bullish |
Dr Lal Pathlabs Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dr Lal Pathlabs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,876.48 | 1.1% | 0.54 | 492 | 2,461 | |
| HOLD | 73,949.36 | 25.44% | 0.69 | 889 | 6,812 | |
| BUY | 64,230.32 | 14.36% | 0.59 | 2,216 | 12,964 | |
| BUY | 13,434.20 | 22.11% | 0.65 | 143 | 704 | |
| BUY | 8,505.79 | 4.31% | 0.55 | 162 | 829 |
Market expectation of Dr Lal Pathlabs Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
84.00%
Buy
4.00%
Hold
12.00%
Sell
Dr Lal Pathlabs Stock’s Investor Sentiment and Interest
Investment in Dr Lal Pathlabs Ltd Shares on INDmoney has grown by 14.21% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:14.21% versus previous 30 day period
Search interest for Dr Lal Pathlabs Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Dr Lal Pathlabs Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Dr Lal Pathlabs Ltd Annual Profit & Loss
Figures in Rupees Crores
Dr Lal Pathlabs Ltd Cash Flow
Figures in Rupees Crores
Dr Lal Pathlabs Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Dr Lal Pathlabs Stock
Check out the Mutual Funds with significant holdings in Dr Lal Pathlabs.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Flexi Cap Fund -Direct Plan - Growth Option | 0.66% | 4178451 | |
 UTI Flexi Cap Fund - Growth Option - Direct | 1.85% | 2560250 | |
 Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth | 1.12% | 1820000 | |
 Nippon India Multi Cap Fund - Direct Plan - Growth | 0.46% | 1516484 | |
 SBI Large & Midcap Fund Direct Growth | 0.53% | 1300000 |
Dr Lal Pathlabs Corporate Actions
View detailed summary of the earnings and dividend history of Dr Lal Pathlabs.
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit fell -15.18% since last year same period to ₹131.30Cr in the Q4 2025-2026. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated 45.08% jump in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends April,2026
In the quarter ending March 2026, Dr Lal Pathlabs Ltd has declared dividend of ₹4.00 per share on 30 Apr 2026 - translating a dividend yield of 1.23%.
Read More about Dividends
Indices Featuring Dr Lal Pathlabs Stock
Check stock indices that include Dr Lal Pathlabs.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, LALPATHLAB stock has moved up by 19.5%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 684.2 Cr → 726.7 Cr (in ₹), with an average increase of 5.9% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 90.5 Cr → 131.3 Cr (in ₹), with an average increase of 31.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 6.94% to 7.87% in Mar 2026 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 16.84% to 18.62% in Mar 2026 quarter
NO EFFECTAgainst Peers
In the last 1 year, Aster DM Healthcare Ltd has given 38.0% return, outperforming this stock by 22.5%
- NO EFFECT
Against Peers
In the last 3 years, Fortis Healthcare Ltd has given 212.5% return, outperforming this stock by 155.7%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 20.29% to 17.18% in Mar 2026 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 53.22% to 53.21% in Mar 2026 quarter
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹702.70Cr as on March 2026 (Q4 FY26)
Net Profit: ₹132.20Cr as on March 2026 (Q4 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| CEO | Arvind Lal |
| E-voting on shares | Click here to vote |
FAQs
What is Dr Lal Pathlabs share price today?
Dr Lal Pathlabs share price today stands at ₹1635.8 as on at the close of the market. Dr Lal Pathlabs share today touched a day high of ₹1677 and a low of ₹1622.4.
What is the 52 week high and 52 week low range for Dr Lal Pathlabs share?
Dr Lal Pathlabs touched a 52 week high of ₹1803 and a 52 week low of ₹1272.6. Dr Lal Pathlabs share price today i.e. is closed at ₹1635.8, which is -9.27% down from its 52 week high and 28.54% up from its 52 week low.
What is Dr Lal Pathlabs's market capitalisation today?
Dr Lal Pathlabs market capitalisation is ₹27,876.48 Cr as on .
How to buy Dr Lal Pathlabs shares?
To buy Dr Lal Pathlabs shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LALPATHLAB or Dr Lal Pathlabs Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Dr Lal Pathlabs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Dr Lal Pathlabs trading volume today?
Dr Lal Pathlabs trading volume is 2.27L as on . This means that 2.27L shares of Dr Lal Pathlabs were bought and sold on the stock market during today's trading session.